141 related articles for article (PubMed ID: 27497473)
21. Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment.
Chen G; Cai L; Chen B; Liang J; Lin F; Li L; Lin L; Yao J; Wen J; Huang H
Diabetes Care; 2011 Dec; 34(12):2586-90. PubMed ID: 22011410
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum galectin-3 level.
Ma S; Li S; Lv R; Hou X; Nie S; Yin Q
J Diabetes Investig; 2020 Sep; 11(5):1295-1302. PubMed ID: 32196999
[TBL] [Abstract][Full Text] [Related]
23. Cholesteryl ester transfer protein B1B1 genotype as a predictor of coronary artery disease in Taiwanese with type 2 diabetes mellitus.
Hsieh MC; Tien KJ; Chang SJ; Lo CS; Hsin SC; Hsiao JY; Hsu SC; Liang HT; Chen HC; Shin SJ; Lin SR
Metabolism; 2007 Jun; 56(6):745-50. PubMed ID: 17512305
[TBL] [Abstract][Full Text] [Related]
24. Constitutive inhibition of plasma CETP by apolipoprotein C1 is blunted in dyslipidemic patients with coronary artery disease.
Pillois X; Gautier T; Bouillet B; Pais de Barros JP; Jeannin A; Vergès B; Bonnet J; Lagrost L
J Lipid Res; 2012 Jun; 53(6):1200-9. PubMed ID: 22474067
[TBL] [Abstract][Full Text] [Related]
25. [Role of cholesteryl ester transfer protein activity and genetic polymorphism in ischemic heart disease in type 2 diabetic patients].
Chaaba R; Smaoui M; Hammami S; Attia N; Ben Hamda K; Masmoudi AS; Mahjoub S; Bouslama A; Ben Farhat M; Girard-Globa A; Hammami M
Tunis Med; 2004 Mar; 82(3):282-8. PubMed ID: 15382463
[TBL] [Abstract][Full Text] [Related]
26. Decreased Serum IGF-1/IGFBP-3 Molar Ratio is Associated with Executive Function Behaviors in Type 2 Diabetic Patients with Mild Cognitive Impairment.
Huang R; Wang P; Han J; Xia W; Cai R; Sun H; Sun J; Wang S
J Alzheimers Dis; 2015; 47(1):85-94. PubMed ID: 26402757
[TBL] [Abstract][Full Text] [Related]
27. Strong Association of Serum GSK-3β/BDNF Ratio with Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients.
Du B; Lian Y; Chen C; Zhang H; Bi Y; Fan C; Bi X
Curr Alzheimer Res; 2019; 16(12):1151-1160. PubMed ID: 31453785
[TBL] [Abstract][Full Text] [Related]
28. Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events.
Ina K; Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ding QF; Zhang J; Yu ZY; Yoon BK; Nomura H; Kuzuya M;
Geriatr Gerontol Int; 2014 Oct; 14(4):806-10. PubMed ID: 24215618
[TBL] [Abstract][Full Text] [Related]
29. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia.
Inazu A; Koizumi J; Mabuchi H; Kajinami K; Takeda R
Horm Metab Res; 1992 Jun; 24(6):284-8. PubMed ID: 1634194
[TBL] [Abstract][Full Text] [Related]
30. Taq1B Polymorphism of Cholesteryl Ester Transfer Protein (CETP) and Its Effects on the Serum Lipid Levels in Metabolic Syndrome Patients.
Maroufi NF; Farzaneh K; Alibabrdel M; Zarei L; Cheraghi O; Soltani S; Montazersaheb S; Akbarzadeh M; Nouri M
Biochem Genet; 2016 Dec; 54(6):894-902. PubMed ID: 27496123
[TBL] [Abstract][Full Text] [Related]
31. CETP and oxidized LDL levels increase in dyslipidemic subjects.
Wang J; Gu Q; Li K; Zhang C
Clin Biochem; 2007 Sep; 40(13-14):995-9. PubMed ID: 17658505
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
33. High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides.
Borggreve SE; Hillege HL; Dallinga-Thie GM; de Jong PE; Wolffenbuttel BH; Grobbee DE; van Tol A; Dullaart RP;
Eur Heart J; 2007 Apr; 28(8):1012-8. PubMed ID: 17409111
[TBL] [Abstract][Full Text] [Related]
34. Association between cholesteryl ester transfer protein TaqIB variants and risk of coronary artery disease and diabetes mellitus in the population of western Iran.
Rahimi Z; Nourozi-Rad R; Vaisi-Raygani A; Saidi MR; Rahimi Z; Ahmadi R; Yarani R; Hamzehee K; Parsian A
Genet Test Mol Biomarkers; 2011 Nov; 15(11):813-9. PubMed ID: 21689002
[TBL] [Abstract][Full Text] [Related]
35. Cholesteryl ester transfer protein and mortality in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study.
Ritsch A; Scharnagl H; Eller P; Tancevski I; Duwensee K; Demetz E; Sandhofer A; Boehm BO; Winkelmann BR; Patsch JR; März W
Circulation; 2010 Jan; 121(3):366-74. PubMed ID: 20065167
[TBL] [Abstract][Full Text] [Related]
36. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
[TBL] [Abstract][Full Text] [Related]
37. Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein.
de Vries-van der Weij J; de Haan W; Hu L; Kuif M; Oei HL; van der Hoorn JW; Havekes LM; Princen HM; Romijn JA; Smit JW; Rensen PC
Endocrinology; 2009 May; 150(5):2368-75. PubMed ID: 19147676
[TBL] [Abstract][Full Text] [Related]
38. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
[TBL] [Abstract][Full Text] [Related]
39. Age Related Prevalence of Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients in the Indian Population and Association of Serum Lipids With Cognitive Dysfunction.
Chakraborty A; Hegde S; Praharaj SK; Prabhu K; Patole C; Shetty AK; Mayya SS; Acharya RV; Hande HM; Prabhu MM; Upadhya D
Front Endocrinol (Lausanne); 2021; 12():798652. PubMed ID: 35035379
[TBL] [Abstract][Full Text] [Related]
40. Association between plasma adipsin level and mild cognitive impairment in Chinese patients with type 2 diabetes: a cross-sectional study.
Guo D; Yuan Y; Huang R; Tian S; Wang J; Lin H; An K; Han J; Wang S
BMC Endocr Disord; 2019 Oct; 19(1):108. PubMed ID: 31651303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
